SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-263994
Filing Date
2020-10-05
Accepted
2020-10-05 17:19:02
Documents
15
Period of Report
2020-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d84765d8k.htm 8-K 29485
2 EX-99.1 d84765dex991.htm EX-99.1 29961
3 EX-99.2 d84765dex992.htm EX-99.2 24198
4 GRAPHIC g84765ex99_2s10g1.jpg GRAPHIC 195356
5 GRAPHIC g84765ex99_2s11g1.jpg GRAPHIC 132486
6 GRAPHIC g84765ex99_2s12g1.jpg GRAPHIC 232196
7 GRAPHIC g84765ex99_2s1g1.jpg GRAPHIC 262564
8 GRAPHIC g84765ex99_2s2g1.jpg GRAPHIC 722925
9 GRAPHIC g84765ex99_2s3g1.jpg GRAPHIC 479632
10 GRAPHIC g84765ex99_2s4g1.jpg GRAPHIC 251370
11 GRAPHIC g84765ex99_2s5g1.jpg GRAPHIC 317496
12 GRAPHIC g84765ex99_2s6g1.jpg GRAPHIC 331220
13 GRAPHIC g84765ex99_2s7g1.jpg GRAPHIC 278702
14 GRAPHIC g84765ex99_2s8g1.jpg GRAPHIC 167233
15 GRAPHIC g84765ex99_2s9g1.jpg GRAPHIC 285727
  Complete submission text file 0001193125-20-263994.txt   5122890
Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address 421 KIPLING STREET PALO ALTO CA 94301 (650) 391-9740
BridgeBio Pharma, Inc. (Filer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38959 | Film No.: 201224517
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences